How much is Atrandi Biosciences worth in 2026?

Atrandi Biosciences has a current valuation of N/A based on their Later Stage VC (Series A) round and secondary market data.

How much funding has Atrandi Biosciences raised?

Atrandi Biosciences has raised N/A in total funding across 2 funding rounds.

Atrandi Biosciences

Discovery Tools (Healthcare)

Atrandi Biosciences valuation and funding history | Last updated: February 18, 2025 | 2 funding rounds

Current Valuation

N/A

As of February 18, 2025

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series A)

$25.0M

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 18, 2025	Later Stage VC (Series A)	$25.0M	N/A	-
August 2, 2023	Seed Round	$5.9M	N/A	-

Valuation Analysis

Current Valuation Metrics

Atrandi Biosciences is currently valued at N/A as of February 18, 2025.

Track Atrandi Biosciences Valuation Updates

Get notified when Atrandi Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Atrandi Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Atrandi Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Atrandi Biosciences Worth in 2026?

Atrandi Biosciences is a leading private company in the Discovery Tools (Healthcare) sector. Track Atrandi Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Atrandi Biosciences Valuation is Determined

Private company valuations like Atrandi Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.